Related Experiment Videos
Methylprednisolone attenuates the pulmonary hypertensive response in porcine meconium aspiration
Abstract:
Severe neonatal aspiration of meconium is frequently complicated by fatal pulmonary hypertension. The protective effect of an i.v. bolus of methylprednisolone on meconium aspiration-induced hypertensive lung injury was studied in anesthetized pigs with adapted lung circulation. Eleven 10-wk-old pigs received 3 mL/kg 20% human meconium via the endotracheal tube. Five of them were pretreated with 30 mg/kg methylprednisolone 30 min before aspiration. Ventilator settings were adjusted to keep arterial PO2 above 8 kPa and arterial PCO2 below 5 kPa. Meconium insufflation induced a biphasic pulmonary pressor response during the 6 h follow-up. Methylprednisolone tended to prevent the early (0-1 h) increase in pulmonary artery pressure and inhibited significantly the second phase (1-6 h) progressive rise in pulmonary artery pressure and pulmonary vascular resistance. This inhibition of resistance increase was most profound in the postarterial segment of the lung circulation, as determined by pulmonary artery occlusion. Additionally, the methylprednisolone pretreated group demonstrated a significant decrease in venous admixture together with improved oxygenation during the late phase after the insult, and further showed evidence of diminished lung edema formation. Although meconium aspiration-induced fall in blood leukocyte concentration was inhibited by methylprednisolone pretreatment, no histologic difference was found in pulmonary leukocyte sequestration. Our results thus show that in adapted porcine lungs methylprednisolone pretreatment improves oxygenation and attenuates the meconium aspiration-induced pulmonary hypertensive response by preventing the increase in the postarterial resistance.
Insights
Methylprednisolone pretreatment significantly reduced pulmonary hypertension and lung injury in pigs after meconium aspiration. This steroid treatment improved oxygenation and decreased pulmonary vascular resistance, offering a potential therapeutic strategy for neonatal respiratory distress.
Area of Science:
- Neonatal Medicine
- Pulmonary Medicine
- Pharmacology
Background:
- Severe neonatal meconium aspiration can lead to fatal pulmonary hypertension.
- Understanding interventions to mitigate meconium aspiration injury is critical.
Purpose of the Study:
- To investigate the protective effects of methylprednisolone on meconium aspiration-induced hypertensive lung injury in a porcine model.
- To assess the impact of methylprednisolone on pulmonary hemodynamics, oxygenation, and lung edema.
Main Methods:
- Anesthetized pigs underwent endotracheal meconium administration.
- A subset of pigs received intravenous methylprednisolone pretreatment.
- Pulmonary artery pressure, vascular resistance, venous admixture, and lung edema were monitored over 6 hours.
Main Results:
- Methylprednisolone pretreatment attenuated the biphasic pulmonary hypertensive response to meconium.
- The steroid significantly inhibited the late-phase increase in pulmonary artery pressure and pulmonary vascular resistance, particularly in the postarterial segment.
- Improved oxygenation and reduced lung edema were observed in the methylprednisolone group.
Conclusions:
- Methylprednisolone pretreatment demonstrates a protective effect against meconium aspiration-induced pulmonary hypertension in a porcine model.
- The steroid acts by preventing increases in postarterial pulmonary resistance and improving oxygenation.
- These findings suggest methylprednisolone as a potential therapeutic agent for neonatal respiratory complications due to meconium aspiration.